Sectoral Asset Management Inc Freeline Therapeutics Holdings PLC Transaction History

Sectoral Asset Management Inc

  • $120 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.04 - $8.9 $1.95 Million - $5.7 Million
-640,714 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$8.15 - $13.9 $112,339 - $191,597
-13,784 Reduced 2.11%
640,714 $5.22 Million
Q1 2021

May 14, 2021
SELL
$12.3 - $18.2 $36,850 - $54,527
-2,996 Reduced 0.46%
654,498 $8.05 Million
Q4 2020

Feb 12, 2021
SELL
$14.94 - $18.3 $2.77 Million - $3.39 Million
-185,357 Reduced 21.99%
657,494 $12 Million
Q3 2020

Nov 13, 2020
BUY
$15.45 - $18.12 $13 Million - $15.3 Million
842,851 New
842,851 $13.2 Million

Others Institutions Holding FRLN

# of Institutions
1
Shares Held
30.1K
Call Options Held
0
Put Options Held
0
View Full List

About Freeline Therapeutics Holdings plc

FRLN Quotes by TradingView
  • Ticker FRLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,972,300
  • Description
  • Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...
More about FRLN
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email